Health
Cleavage site recognition by SARS-CoV-2 main protease as new antiviral drug target – News-Medical.Net
Many research groups have and are investigating main protease inhibitors as antiviral drugs, and in a paper recently uploaded to the bioRxiv* preprint server, a…
The main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cleaves the proteins produced by the virus at various stages of replication and maturation. Highly conserved across coronaviruses due to the essential functional role of the enzyme, it also makes an appealing drug target.
Many research groups have and are investigating main protease inhibitors as antiviral drugs, and in a paper recently uploaded to the bioRxiv* preprint server, a team of researchers examine the crystal…
-
General19 hours agoOsborne Park Football Club suspended for two years after Stephen Hawking costume controversy
-
General20 hours agoMelbourne Cup five quick hits: Melham magic, Blake Shinn falls, and concern over blood from Half Yours’s mouth
-
Noosa News21 hours agoFatal traffic crash, Cooloola Cove
-
General18 hours agoAustralia warned of assassination attempts by regimes